Press Releases

MicrobioSeq Releases Microecology and Cancer Solutions to Accelerate Your Cancer Research and Discovery

FDA Grants Orphan Drug Designation for Shylicine™

Vanessa Biotech has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the drug Shylicine™

Science 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers

Matexcel Offers a Comprehensive List of Graphene Products

Vanessa Research is now Vanessa Biotech

Continuous manufacturing μLOT® enabling technology could cut pharma industry’s use of toxic chemicals by one hundred times

Speaking at the ‘Innovative Chemistry for Peptide Manufacturing and Analysis’ conference, SB3000’s Chief R&D Officer Jens Bukrinski revealed that continuous manufacturing μLOT® technology could reduce the pharmaceutical industry’s use of toxic chemicals by 100 times.

Ceryx Medical appoints Chas Taylor as Chairman

Ceryx Medical, the business behind a revolutionary technology that could significantly change the way patients with serious heart problems are treated, has appointed Chas Taylor, a leading medical devices entrepreneur, as Chairman.

COPD Foundation and DevPro Biopharma Join Forces to Develop Treatments for People with COPD and Related Lung Conditions

COPD Foundation and DevPro Biopharma enter into a strategic alliance to develop more effective treatments for people with chronic lung conditions and get them to patients sooner.

CD BioSciences is Ready to Provide Clinical Data Management Service

CD BioSciences, a US based supplier of one-stop clinical trial services, has announced to provide global scientists with clinical data management, analysis and reporting service.

RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine

Notes to editors Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. RDIF has established joint strategic partnerships with leading international co-investors from over 18 countries attracting over $40 bn of capital. Further information can be found at rdif.ru For more information about the Sputnik vaccine please visit sputnikvaccine.com/ Stelis Biopharma Pvt. Ltd. (Stelis) is a vertically integrated biopharmaceutical company. Stelis offers end-to-end state-of-the-art CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. Its operations include R&D, process development, scale-up & end-to-end cGMP manufacturing capabilities from drug substance through drug product in all formats and packaging. Stelis is also developing select follow-on biologic products for global markets in niche and commercially attractive disease categories. Stelis has recently forayed into Vaccine manufacturing with a capability to do multiple vaccine types. Stelis’ state-of-the-art research & development facility and 200,000 sq. ft. fully integrated cGMP manufacturing facility are located in Bengaluru, India. Facilities cater to the development and cGMP manufacturing of biologics and injectables conforming to international standards. For more information visit www.stelis.com Strides, listed on the BSE Limited (532531) and National Stock Exchange of India Limited (STAR), is a global pharmaceutical company headquartered in Bengaluru, India. The Company mainly operates in the regulated markets and has an “in Africa for Africa” strategy along with an institutional business to service donor-funded markets. The Company’s global manufacturing sites are located in India (Chennai, Puducherry and two locations in Bengaluru), Singapore, Italy (Milan), Kenya (Nairobi) and the United States (Florida). The Company focusses on “difficult to manufacture” products that are sold in over 100 countries. Additional information is available at the Company’s website at www.strides.com

THREAD and CureClick Partner to Accelerate Recruitment for Decentralized Clinical Trials

Seven Bridges Launches the GRAF™ Population Solution — Population-Specific Tools and Services to Enhance Genetic Variation Discovery

Bioinformatics methods suffer from a significant loss of accuracy when used on sequencing data from under-represented populations because the genetic information of such populations cannot be captured in the linear reference genome. The inherent bias in the industry’s current reference genome favors the European population. A pan-genome approach can provide significant improvements, but it is still suboptimal. The Seven Bridges GRAF Population Solution is ancestry-aware and, therefore, more accurate than both linear and pan-genome approaches.

VisualDx Now Available at Northeast Ohio Medical University

Baltimore Aircoil Company Highlights ENDURADRIVE® Fan System for Ideal Cooling in Mission-Critical Environments

ENDURADRIVE® Fan System provides peace of mind and unmatched reliability, thanks to its advanced design

Formedix Launches All-in-One Cloud-Based Clinical Metadata Repository and Study Automation Platform to Simplify and Expedite Clinical Trial Design and Build

Formedix announces today the launch of ryze, an innovative all-in-one cloud-based clinical metadata repository (MDR) and study automation platform, specifically developed to accelerate and streamline the design, build and submission of clinical trials in compliance with CDISC and NCI Controlled Terminology.

ObvioHealth and RedHill Biopharma Launch First in Kind Remote COVID-19 Therapy Trial Incorporating Highest Level of At-home Patient Monitoring to Date

Auxita and MyMeds&Me Announce Strategic Partnership to Deliver Integrated Digital Pharmacovigilance Capabilities

This partnership integrates MyMeds&Me’s validated safety data capture solution into Auxita, enabling healthcare providers, patient support programs and pharmaceutical companies to capture and manage data more efficiently.

CRISPR/Cas9 Gene Editing Service Now Available by the GutFlora Omics Platform

Alfa Chemistry Released Ion Sensor Materials for Analytical and Chromatography Applications

AARDEX and Schreiner MediPharm reinforce their collaboration to Enhance Medication Adherence Management

AARDEX Group, the world leader in medication adherence solutions, continues to build up its ecosystem and to bridge GMP to GCP world in Clinical Trials by reinforcing their strategic partnership with Schreiner MediPharm, a global specialist in innovative functional labels and smart packaging solutions for the pharmaceutical industry.